Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
Lactobacillus rhamnosus F-1
Biotech Pharmaceutical Co.,
Allergic Rhinitis
1 trial -
Lenalidomide
The First People's Hospital of Lianyungang
Diffuse Large B Cell Lymphoma
1 trial -
Letrozole -Berberine
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Polycystic Ovary Syndrome
1 trial -
Leuprorelin acetate + Sintilimab
The First People's Hospital of Lianyungang
NSCLC, Stage III
1 trial -
Levetiracetam (Keppra)
United Therapeutics Europe Ltd
Alcohol Abuse
1 trial -
Lidocaine Hydrochloride, Injectable
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Primary Liver Cancer
1 trial -
Lidocaine IV
Samsung Bioepis NL B.V.
Colorectal Cancer
1 trial -
Linaclotide
Second Affiliated Hospital of Xi'an Jiaotong University
Bowel Preparation
1 trial -
Lipid-based nutrient supplement
United Therapeutics Europe Ltd
Malnutrition
1 trial -
Liposomal Doxorubicin
United Therapeutics Europe Ltd
Ovarian Cancer
1 trial -
Liquid Biopsy (SPOT-MAS Assay)
Hospital Authority, Hong Kong
Lung Cancer
1 trial -
Liquid Biopsy Early Screening
The First People's Hospital of Lianyungang
Liquid Biopsy for Early Screening of Lung Cancer
1 trial -
Low dose midazolam
Hospital Authority, Hong Kong
Intubation
1 trial -
Low potassium content vegetables
Xiyuan Hospital of China Academy of Chinese Medical Sciences
End-stage Renal Disease
1 trial -
Low strength nicotine e-liquid
BRIGHT MINDS BIOSCIENCES INC.
Electronic Cigarette Use
1 trial -
Low-fat milk group
BRIGHT MINDS BIOSCIENCES INC.
Metabolic Syndrome
1 trial -
Lubiprostone
Takeda
Constipation-predominant Irritable Bowel Syndrome
1 trial -
Lubiprostone
Takeda
Diabetes Mellitus, Type 1
1 trial -
Luvometinib
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Langerhans Cell Histiocytosis (LCH)
1 trial -
MDA
BRIGHT MINDS BIOSCIENCES INC.
Healthy
1 trial -
MRI head
Cardiff Oncology
Cystic Fibrosis
1 trial -
MRI scan
United Therapeutics Europe Ltd
Preterm Birth Complication
1 trial -
MTBF regimen
The First People's Hospital of Lianyungang
Relapse Leukemia
1 trial -
MV-PRS Sub-study
United Therapeutics Europe Ltd
Prostate Cancer
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources